Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma

Abstract

TMR is an important independent predictor of survival for melanoma patients. If confirmed by studies from other centers, it has the potential to further improve the accuracy of melanoma staging, as well as to define more rigidly the risk categories for patients entering clinical trials.